Showing results (31-40 of 62) with videos related to
Sort By:
Pageof 7
Gynecologic Oncology|March 18, 2014
Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancerIngrid J Rowlands, Vanessa L Beesley, Monika Janda, et al.Gynecologic Oncology|June 12, 2021
What happens after menopause? (WHAM): A prospective controlled study of sleep quality up to 12 months after premenopausal risk-reducing salpingo-oophorectomyMartha Hickey, Katrina M Moss, Efrosinia O Krejany, et al.Journal of Gynecologic Oncology|October 30, 2013
Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG studyPrunella Blinman, Corona Gainford, Mark Donoghoe, et al.Journal of Sleep Research|April 26, 2022
Cancer sleep symptom-related phenotypic clustering differs across three cancer specific patient cohortsKristina Kairaitis, Ayey S Madut, Harini Subramanian, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 14, 2018
Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort StudyBrian Z Ring, Rajmohan Murali, Robert A Soslow, et al.Gynecologic Oncology|July 27, 2021
What happens after menopause? (WHAM): A prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomyMartha Hickey, Katrina M Moss, Efrosinia O Krejany, et al.The Lancet. Public Health|January 29, 2026
Uptake and performance of self-collection offered through primary care to all eligible participants in a national cervical screening programme in Australia: a retrospective cohort studyFarhana Sultana, Megan Smith, Marion Saville, et al.Frontiers in Neuroscience|October 11, 2021
Irregular Sleep/Wake Patterns Are Associated With Reduced Quality of Life in Post-treatment Cancer Patients: A Study Across Three Cancer CohortsRitu Trivedi, Hong Man, Ayey Madut, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancerLyndee L Scurr, Alexander D Guminski, Yoke-Eng Chiew, et al.Gynecologic Oncology|December 3, 2014
Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancerVanessa L Beesley, Ingrid J Rowlands, Sandi C Hayes, et al.Pageof 7